1 Min Read
Nov 29 (Reuters) - RaQualia Pharma Inc
* Says it ends license agreement with Maruishi Pharmaceutical Co Ltd regarding EP4 antagonist
Source text in Japanese:goo.gl/CxExhq
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.